Resmed (RMD) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Powered by 
Analysis
Resmed (RMD) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.47% |
| Mar 31, 2026 | 47.92% |
| Dec 31, 2025 | 16.94% |
| Sep 30, 2025 | 14.34% |
| Jun 30, 2025 | 16.38% |
| Mar 31, 2025 | 17.48% |
| Dec 31, 2024 | 16.50% |
| Sep 30, 2024 | 20.98% |
| Jun 30, 2024 | 40.31% |
| Mar 31, 2024 | 23.31% |
| Dec 31, 2023 | 10.87% |
| Sep 30, 2023 | 15.72% |
| Jun 30, 2023 | 15.90% |
| Mar 31, 2023 | 16.12% |
| Dec 31, 2022 | 88.20% |
| Sep 30, 2022 | 19.57% |
| Jun 30, 2022 | 39.83% |
| Mar 31, 2022 | 15.31% |
| Dec 31, 2021 | 21.33% |
| Sep 30, 2021 | 21.75% |